Evaluation of lung ultrasound as a guiding tool for treatment adjustment in patients with heart failure admitted to hospital

Effect of a therapeutic strategy guided by lung ultrasound on 6-month outcomes in patients with heart failure. The EPICC trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN95766678

Enrollment

152

Registered

2022-03-21

Start date

2018-09-01

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure Circulatory System

Interventions

Randomized, multicenter, single-blind clinical trial in patients discharged from Internal Medicine Departments after hospitalization for decompensated HF. Randomization was performed via an online too

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age older than 18 y 2. NYHA functional class =II at inclusion 3. Able to attend ambulatory follow-up visits

Exclusion criteria

Exclusion criteria: 1. Life expectancy 3 mg/dl or chronic renal insufficiency in dialysis 9. Severe valve stenosis 10. Participation in another randomized study

Design outcomes

Primary

Measure	Time frame
Cardiovascular death, admission due to heart failure, emergency department visit due to heart failure, diuretic administration at day hospital measured using patient records at 6 months	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026